Informations générales (source: ClinicalTrials.gov)
Identification of Neurocognitive Disorders by General Practitioners in Primary Care (TROCOMEGE)
Interventional
N/A
Hospices Civils de Lyon (Voir sur ClinicalTrials)
février 2020
août 2024
29 juin 2024
Neurocognitive disorders (NCD) are today often largely underdiagnosed or diagnosed in
late stages in France. Indeed the ALzheimer COoperative Valuation in Europe (ALCOVE)
study stated that about 50% of people living with NCD remain undiagnosed until late
severe stages with a deep autonomy loss inducing at risk behaviours and/or behavioural
crisis. The French High Authority of Health (Haute Autorité de Santé - HAS) and ALCOVE
recommend a timely diagnosis at a time when the specific intervention help to implement
secondary or tertiary prevention dynamics that would delay severe complications and help
to maintain a reasonable quality of life for both the patient and the caregiver.
Moreover, the representatives of the National College of General Practitioners, the
French Federation of Memory Centres, the French Federation of Gerontology and Geriatrics,
the French Federation of Neurology, the French Society of Psychogeriatrics and the
National Plan on Neurodegenerative Diseases designed a hierarchized and tailored
diagnosis strategy of NCD promoting a shared diagnosis between the General Practitioner
(GP) and specialists of NCD. It therefore appears crucial to determine the diagnosis
value of a short duration strategy assessing the complaint, cognition and autonomy in
primary care to detect NCD and referring to a specialist to perform the etiological
diagnosis. The identification of NCD by GP in primary care (TROCOMEGE) study aims at
assessing the positive and negative predictive values of a NCD diagnosis strategy through
the assessment of the subjective memory complaint, the cognitive status and the autonomy
level in primary care. It relies on the clinical impression of the GP, a cognitive
complaint interview for complaint and functional assessment thanks to the General
Practitioner assessment of Cognition (GP-Cog, part 2) tool and the cognitive assessment
thanks to the Six-Item Cognitive Impairment test (6-CIT).
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Hôpital des Charpennes - 69100 - Villeurbanne - France | Pierre Krolak Salmon, Pr | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patient aged 65 and over,
- Patient expressing a cognitive complaint (memory, language, sense of time and place
disorientation for example) to his/her general practitioner; the complaint can be
provided by an informal caregiver and /or, presenting with "at risk" behaviour*
possibly related to a NCD (mistaking medicine or forgetting medical consultation,
forgetting hot meals, losing him/herself for example...),
- Patients able to understand the specifications of the study and to realize it
(vision, audition, language...)
- Patient who has been informed and has consented to the study (himself/herself and by
a trusted person/a family member if applicable) as established by the "article L.
1121-8 du Code de la Santé Publique".
- Registered with a social security system
- Patient aged 65 and over,
- Patient expressing a cognitive complaint (memory, language, sense of time and place
disorientation for example) to his/her general practitioner; the complaint can be
provided by an informal caregiver and /or, presenting with "at risk" behaviour*
possibly related to a NCD (mistaking medicine or forgetting medical consultation,
forgetting hot meals, losing him/herself for example...),
- Patients able to understand the specifications of the study and to realize it
(vision, audition, language...)
- Patient who has been informed and has consented to the study (himself/herself and by
a trusted person/a family member if applicable) as established by the "article L.
1121-8 du Code de la Santé Publique".
- Registered with a social security system
- Institutionalized patients
- Patients unable to understand the purpose of the study,
- Patients with neurocognitive disorders already diagnosed
- Patients under legal protection
- Patients with auditory or visual disorders which do not allow to perform the
assessment
- Patients who do not want to go to the Memory Clinic
- Patients with severe disease commit the prognosis in relatively short term
- Participation to another trial that would interfere with the present study
- Patient with severe anxiety or depression preventing from any reliable
neuropsychological assessment.